← back to picks
Founded 1975 (Paris) Reporting EUR Credit Aaa/AAA Valuation 2026-05-24 Damodaran FCFF · 1000-iter MC FCFF · Dark v3

Market prices an AI-loser; this DCF prices a muddle-through with regression β · +61.9% margin of safety

Market sits below MC p5 floor

Ipsos trades at €36.70 against a base-case intrinsic of €96.23/sh after a 10% governance haircut. Even the Monte Carlo p5 of €66 sits well above today's tape — the market is pricing the AI-loser branch in full, not the probable muddle-through.

DCF €96 MARKET €36.70 p5 €66 p95 €110 €25 €120
SECTOR Information Services GEO US 26% · FR 14% · UK 9% MC σ ±€13.1/sh GOVERNANCE DT & Partners 11.5%/20%vote · 10% haircut QUALITY ROIC 13.6% · IG rating
Intrinsic / share
€96.23
post 10% gov
Market / share
€36.70
Euronext Paris
Margin of safety
+61.9%
vs intrinsic
Enterprise value
€4.97B
68.1% terminal
Cost of equity / debt
5.43% / 2.09%
β 0.59 · CRP 0.90%
Terminal ROIC / g
12.00% / 2.00%
spread ~499bp

What it sells, where it sells

Operating segments

€2.5B
Single operating segmentIpsos reports as one IFRS-8 unit; mix discipline lives within the regional split 100%
Ipsos.Digital + GMSGrowth driver inside the segment — €85M (2023) ramping double-digit, the margin-uplift case ~5%
Traditional researchSurveys, polling, panels — the AI-exposure pool that the bear case targets ~95%

Ipsos is a single-segment business by IFRS — the operating debate is really between the small, fast-growing Ipsos.Digital/GMS growth driver (the platform-shift hedge) and the 95% legacy survey base whose pricing power AI is actively repricing.

Country mix (revenue-weighted CRP input)

🇺🇸United States 26.0%
🇫🇷France 14.0%
🇬🇧United Kingdom 9.0%
🇩🇪Germany 6.0%
🇨🇳China 6.0%
🇮🇹Italy 4.0%
🇧🇷Brazil 4.0%
🇸🇦Saudi Arabia / Mid-East 3.0%
🌍Other (12 countries) 28.0%

US + EU-4 (FR/UK/DE/IT) = ~59% of revenue — a US recession or sustained EUR strength against USD (Q1 2026 already took 5.4 pts off reported revenue) is the macro path that hurts most.

Background — five things to know before the case

Context the share price doesn't carry on its face. Skim this once and the bull / bear bullets below stop reading as inside baseball.

Where we diverge from the sector

Each row asks: if we'd used the sector median for this one assumption instead of our override, how much would the share price change? Negative = our override is more conservative (worth less); positive = more aggressive (worth more). Skim down the rightmost column to see which bets are doing the work.

AssumptionOur inputDamodaran sectorΔWhy we diverge
Levered β0.591.00 (re-levered 0.87)-41%5Y regression (Yahoo + SimplyWallSt both 0.59); family-controlled French market researcher has lower covariance than the broad Info Services aggregate that includes higher-β data/SaaS names.
Sales-to-capital1.052.71-61%Industry average includes pure-software/data names with no goodwill carry. Project-based services peers run 1.0-1.5; Ipsos's ~€1.4B M&A goodwill stock is the real reinvestment line.
Target op margin (Y10)13.0%11.8%+10%Captures half of management's Horizons 13.5%-by-2028 uplift, discounted for the 2022-2025 plan miss and AI commoditization pressure on the survey base.
Terminal growth2.0%≤ 2.4% (EUR rf)-40bpModestly below EUR risk-free to price the AI dispersion / mature-industry risk into the perpetuity, rather than baking it into one specific forecast year.
Governance haircut10%0-5% (standard)+5ppDT & Partners holds 11.5% economic / ~20% voting via French double-voting-rights; not extractive but minority-shareholders cannot block. Modest premium over the 5% standard public-company haircut.
Negative Δ = our override is more conservative; positive = more aggressive than the sector default.

The story & the five claims

The 10-year story this DCF is built on, plus the five anchor claims that translate the story into model inputs.

The 10-year story

Ipsos is a muddle-through story. Year-1 revenue grows ~2.5%, the midpoint of management's reaffirmed FY2026 guide trimmed for the Q1 -1.4% miss. Years 2-3 ramp to ~3.5% as BVA Family and infas annualize and the Horizons spend starts to compound; Years 4-7 taper to 3% as easy comparables fade and AI compresses pricing on the low end of survey work; Years 8-10 converge to the 2.0% terminal, modestly below the EUR risk-free. Operating margin grinds from 12.3% (FY2025) to 13.0% by Year 7 — half the Horizons uplift, capturing the Ipsos.Digital / GMS mix shift and continued gross-margin expansion (64.2% in 2020 → 68.7% in 2025) without betting on the full 13.5-14% management target. Reinvestment runs at 1.05 sales-to-capital, dominated by tuck-in M&A goodwill rather than capex — the model Ipsos has actually executed for 100+ deals. Terminal ROC pinned at 12%, a ~3pp spread above the new ~4.4% WACC.

Two debates worth pressure-testing

Is the 0.59 regression β a structural truth or a noise-driven artefact?
Our view: Two independent sources (Yahoo, SimplyWallSt) report the same 5Y β of 0.59 — the agreement makes a noise story implausible. Family-controlled French listings with structural foreign-investor underweighting commonly run below the global industry aggregate that includes higher-β US data/SaaS names. The 41% divergence is large but explainable; we override.
Does the AI-loser branch actually live in the muddle-through DCF, or only in scenarios.yaml?
Our view: Partially baked in. Terminal growth at 2.0% (below EUR rf 2.4%), Y4-7 growth taper, and the 13.0% margin ceiling (vs management's 13.5% target) all price modest AI commoditization. The full bear — synthetic data displacing 30-50% of survey revenue — is a discrete branch and belongs in scenarios.yaml, not the base case.
1
Defend, don't expand share. Revenue €2.53B → €3.32B by 2035 (~2.75% CAGR). Y1 2.5%, ramp to 3.5% by Y3 on BVA/infas annualization, taper to 2% terminal.
2
Half the Horizons margin uplift. Op margin 12.3% → 13.0% by Y7. Captures Ipsos.Digital/GMS mix shift and gross-margin trend; discounts the 13.5% management target for AI commoditization.
3
M&A-funded reinvestment, not capex. Sales-to-capital 1.05 (vs 2.71 industry average) reflects ~€1.4B goodwill stock from 100+ acquisitions, not inefficiency — ROIC has held at 12-14% across the pace.
4
7-year convergence. Margin reaches 13.0% by Y7; growth tapers to 2% terminal by Y10. Slower than Damodaran's typical 5-year mature-company glidepath — appropriate for an evolutionary mix shift, not a step change.
5
No failure risk, terminal ROC 12%. Investment-grade rating, €318M cash, terminal growth 2.0% (below EUR rf 2.4%), terminal WACC override 7% absorbs the β path back up from 0.59 to industry norms in steady state.
Where we diverge from sell-side
  • β re-anchored to regression (0.59 vs industry 1.00). Sell-side uses bottom-up sector β; we trust the 5Y regression that two sources agree on. Lifts intrinsic ~10/sh vs the industry-β run.
  • Margin lift only halfway to Horizons. Sell-side bulls model the full 13.5-14% management target; we land at 13.0% to discount the 2022-2025 plan miss and AI pricing pressure.
  • Sales-to-capital 1.05, not industry 2.71. The M&A-goodwill operating model is the right baseline — applying the industry default would massively understate the capital base and overstate FCFF.
  • Governance haircut 10%, above the 5% standard. French double-voting-rights gives DT & Partners 20% voting on 11.5% economic; not extractive, but minorities cannot block. Modest premium over the public-company baseline is warranted.
Two-sided case — bear anchors
  • AI displaces 30-50% of survey revenue by 2032. Synthetic data + PersonaBots become "good enough" for concept tests and tracking; organic turns -1 to -3% from 2027; margin compresses to 8-10% on volume deleverage.
  • Plan miss repeats. Same management that missed 2022-2025 misses 2026-28; Q1 2026 -1.4% is the first datapoint of a multi-year underperformance, not a Horizons-ramp artefact.
  • EUR strength persists. ~33% of revenue is Americas (mostly USD); sustained EUR appreciation continues to take 4-6 pts off reported revenue annually.
  • M&A pace breaks ROIC. One bad large deal among the next 15 tuck-ins impairs goodwill (~€1.4B stock) and breaks the 12-14% ROIC band that supports the terminal spread above WACC.
  • CEO transition stumbles. Stoclet is internal but Poitou is new in the Global CEO seat — Horizons execution risk above the baseline plan-slippage history.

Risks to thesis (tail, not bear case)

HIGHAI displacement of survey base
Binary outcome — synthetic respondents may absorb 30-50% of concept-test and tracking work over 5-10 years. The pivot (Synthesio, PersonaBots, Digital Twin) is real but unproven at scale.
MEDExecution credibility
Prior 2022-2025 plan was not delivered. New Horizons targets 5%+ organic by 2028 from a Q1 2026 starting point of -1.4%. Oddo BHF already flagged the credibility gap.
MEDEUR strength / Americas FX drag
Q1 2026 took 5.4 pts off reported revenue from FX. ~33% of revenue is Americas-USD; sustained EUR appreciation is a multi-year reported-growth headwind.
LOWGovernance / double-voting rights
DT & Partners 20% voting on 11.5% economic. Family has been a buyer at €50-65 and supported orderly transition; not extractive, but minorities cannot block. Captured in the 10% haircut.
LOWM&A goodwill impairment
~€1.4B goodwill on €2.5B revenue. ROIC 12-14% across 15+ deals since 2023 says capital is being created, but one bad large deal could impair.

10-year forecast

Revenue €2.60B → €3.33B over 10y (~2.75% CAGR); operating margin grinds from 12.3% to 13.0% by Y7.

Y1 Y2 Y3 Y4 Y5 Y6 Y7 Y8 Y9 Y10 0 3.3B rev (EUR) 0% 15% op margin revenue FCFF op margin

Monte Carlo distribution

With β re-anchored to the 0.59 5Y regression, the entire MC distribution sits above market: even the p5 floor at €66/sh is ~81% above today's €36.70. The DCF says either the regression β is wrong, or the market is.

1000 iterations randomising the central uncertainties. P(intrinsic < market €36.70) = 0.0%.

p5 p25 p50 p75 p95 market 36.70 33.4 87.3 123.4 freq equity / share (EUR)

Mean €87.52 ± €13.14.

Cost of capital build
Risk-free rate 2.40%
Mature-market ERP 4.23%
Levered β 0.59
Weighted CRP 0.90%
Cost of equity 5.43%
Pre-tax cost of debt (synth Aaa/AAA) 2.09%
D / V ~15%
WACC 4.43%
Full year-by-year DCF
Year Revenue Op mgn EBIT EBIT(1−t) Reinvest FCFF PV
1 €2.60B 12.35% €321M €238M €72M €165M €158M
2 €2.68B 12.46% €334M €247M €74M €173M €158M
3 €2.76B 12.56% €347M €256M €77M €180M €158M
4 €2.84B 12.67% €360M €266M €79M €188M €158M
5 €2.93B 12.78% €374M €277M €81M €196M €158M
6 €3.01B 12.89% €389M €288M €84M €204M €158M
7 €3.11B 13.00% €404M €300M €86M €213M €158M
8 €3.19B 13.00% €414M €308M €79M €229M €161M
9 €3.26B 13.00% €424M €316M €71M €245M €162M
10 €3.33B 13.00% €433M €322M €62M €260M €161M
Methodology & flags

Damodaran FCFF DCF, 10y explicit + perpetuity. R&D capitalised; IFRS-16 leases in book debt. Synth credit Aaa/AAA. CRP from revenue-weighted country mix × Damodaran 2026 CRPs. Levered β 0.59 (5Y regression Yahoo/SimplyWallSt, overrides industry prior 0.87→1.00). Monte Carlo: 1000 iterations. Engine v1.0.0 · result: /Users/valentin/Documents/notes_jiliac_labs/Finance/Damodaran/valuations/ips/output/2026-05-25-result.json

  • R&D cap: OFF · Lease cap: OFF · Failure: OFF · ESO: OFF
  • Governance haircut: 10% (€106.92 > €96.23)
  • Sensitivity tornado: not run